On the first day of listing, the so-called’Kyobo Man,’ who swept through SK Bioscience in large quantities, sold most of its stocks on the 19th. It is estimated that it made a profit of about 7 billion won in one day.
According to the financial investment industry on the 19th, Kyobo Securities ranked first in the purchase window on the first day of SK Bioscience’s listing. The total trading volume recorded 760,000 shares, and 52,9814 shares, which account for about 75%, were bought from Kyobo Securities. Most of the volume traded in the market has been wiped out. The purchase amount amounted to about 89.5 billion won.
In general, if the stock price goes directly to the upper limit immediately after opening on the listing date, who quickly placed the order determines the success of the order execution. For this reason, the stock market estimates that an investor using the Kyobo Securities window quickly placed large orders and monopolized the stock.
On this day, the day after listing, Kyobo Securities poured orders from the beginning of the market. Looking at the trading trend, Kyobo Securities sold 210,000 shares immediately after opening, and 120,000 shares were sold at 9:2. In about 20 minutes, 530,000 stocks were sold to the market. This is why most of the stocks purchased the day before are expected to run out.
Although it is not possible to determine who the trading entity is, it is estimated that the investor bought 530,000 shares of SK Bioscience for 169,000 won and sold it at about 182,000 won per share. In a single day, it was about 7 billion won.
An official in the securities industry said, “Even as a securities company, we do not have the authority to check who placed the order,” he said.
[김경택 매경닷컴 기자 [email protected]]
[ⓒ 매일경제 & mk.co.kr, 무단전재 및 재배포 금지]